NEJM publishes final results from phase two study showing vaccines can reduce rate of sustained TB infections

(Burness) Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced the publication of the full results from a Phase 2, randomized, controlled clinical trial of two TB vaccines-- the currently available BCG vaccine and an investigational vaccine, H4:IC31--in the New England Journal of Medicine (NEJM).

from EurekAlert! - Social and Behavioral Science https://ift.tt/2us1Dvw